Publication Name	World Journal of Clinical Oncology
Manuscript ID	91057
Country	Spain

Received	2023-12-21 00:59
Peer-Review Started	2023-12-21 00:59
To Make the First Decision
Return for Revision	2024-01-25 21:18
Revised	2024-02-01 23:20
Second Decision	2024-03-11 02:43
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2024-03-11 07:24
Articles in Press	2024-03-11 07:24
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-04-10 01:40
Publish the Manuscript Online	2024-04-22 09:51

ISSN	2218-4333 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Editorial
Article Title	Management of lateral pelvic lymph nodes in rectal cancer: Is it time to reach an Agreement?
Manuscript Source	Invited Manuscript
All Author List	Sigfredo E Romero-Zoghbi, Fernando López-Campos and Felipe Couñago
Funding Agency and Grant Number
Corresponding Author	Felipe Couñago, MD, PhD, Chief Doctor, Department of Radiation Oncology, GenesisCare - Hospital Universitario Vithas Madrid La Milagrosa, Calle de Modesto Lafuente, 14, Chamberí, Madrid 28010, Spain. felipe.counago@genesiscare.es
Key Words	Rectal cancer; Lateral pelvic lymph node metastases; Pelvic lymph node dissection; Total neoadjuvant therapy; Selective management of the lateral pelvic nodes; Prophylactic management of the lateral pelvic nodes; Chemoradiotherapy; Total mesorectal excision
Core Tip	The lack of consensus in managing metastatic lateral pelvic lymph nodes in stage II/III rectal cancer patients below the peritoneal reflection, with differing medical strategies between East and West, generates uncertainty due to limited available evidence. Characteristics such as lymph node size, neoadjuvant treatment, and selective dissection of lateral pelvic lymph nodes are part of the strategies, but the first steps toward a solid and global consensus must be taken to resolve the uncertainties present in this field.
Publish Date	2024-04-22 09:51
Citation	Romero-Zoghbi SE, López-Campos F, Couñago F. Management of lateral pelvic lymph nodes in rectal cancer: Is it time to reach an Agreement? World J Clin Oncol 2024; 15(4): 472-477
URL	https://www.wjgnet.com/2218-4333/full/v15/i4/472.htm
DOI	https://dx.doi.org/10.5306/wjco.v15.i4.472

Full Article (PDF)	WJCO-15-472-with-cover.pdf
Manuscript File	91057_Auto_Edited-LJH-YJP.docx
Answering Reviewers	91057-Answering reviewers.pdf
Audio Core Tip	91057-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	91057-Conflict-of-interest statement.pdf
Copyright License Agreement	91057-Copyright license agreement.pdf
Peer-review Report	91057-Peer-review(s).pdf
Scientific Misconduct Check	91057-Bing-Liu JH-2.png
Scientific Misconduct Check	91057-CrossCheck.png
Scientific Editor Work List	91057-Scientific editor work list.pdf